Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET

Por Koolen, B. B., Vogel, W. V., Vrancken Peeters, M. J. T. F. D., Loo, C. E., Rutgers, E. J. Th., Valdés Olmos, R. A.
Publicado em 2012

Enrichment of high-grade tumors in breast cancer gene expression studies

Por van Seijen, M., Mooyaart, A. L., Mulder, L., Hoogstraat, M., Drukker, C. A., Loo, C. E., Pouw, B., Sonke, G. S., Wesseling, J., Lips, E. H.
Publicado no Breast Cancer Res Treat (2017)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Por Straver, M. E., Rutgers, E. J. Th., Rodenhuis, S., Linn, S. C., Loo, C. E., Wesseling, J., Russell, N. S., Oldenburg, H. S. A., Antonini, N., Vrancken Peeters, M. T. F. D.
Publicado em 2010

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

Por Rigter, L S, Loo, C E, Linn, S C, Sonke, G S, van Werkhoven, E, Lips, E H, Warnars, H A, Doll, P K, Bruining, A, Mandjes, I A, Vrancken Peeters, M J, Wesseling, J, Gilhuijs, K G, Rodenhuis, S
Publicado em 2013